Thomas Hildebrandt

Thomas Hildebrandt has a diverse work experience in the pharmaceutical industry. Thomas is currently working at Neuraxpharm as the Head of Corporate Marketing for Multiple Sclerosis, where they are responsible for launching a new therapy in European markets and developing effective marketing strategies. Prior to that, they held senior positions at Sanofi, including Senior Director of Global Marketing for Neurology/Multiple Sclerosis, and Director of Marketing Neurology in Germany, Austria, and Switzerland. Thomas also worked at Amgen GmbH as the Director of Sales & Marketing Effectiveness and at Biogen in various roles, such as Director of Commercial Operations International and Associate Director of Global Neurology Marketing. Earlier in their career, they worked at Boehringer Ingelheim and Bayer AG in marketing and sales positions. Overall, Thomas Hildebrandt has extensive experience in marketing and sales in the pharmaceutical industry.

Thomas Hildebrandt obtained a Vordiplom (Pre-diploma) in Economics from The University of Bonn from 1987 to 1989. Thomas then pursued their M. Sc. (Diplom Kaufmann) in Marketing at Technische Universität Berlin from 1989 to 1993. In 1991, they participated in an MBA exchange program with TU Berlin at The University of British Columbia, specializing in Business Administration.